Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 205F23-A | — |
worse symptoms during his covid infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (worse symptoms during his covid infection) in an adult male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. 205F23-A) for COVID-19 prophylaxis. The patient's past medical history included CPAP (sleep apnea and uses CPAP). Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 VACCINE (Batch Lot No: 04A2A, Dose 1) on 05-Mar-2021, Moderna COVID-19 VACCINE (Batch Lot No: 007B21A, Dose 2) on 04-Apr-2021, Moderna COVID-19 VACCINE (Batch Lot No: 051F21A, Dose 3) on 03-Nov-2021, Spikevax (Batch Lot No: 016B22A, Dose 4) on 05-Jul-2022, Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) (Batch Lot No: 059F22A, Dose 5) on 26-Oct-2022, Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) (Batch Lot No: A87170B and Dose 6) on 09-Jun-2023. Past adverse reactions to the above products included No adverse effect with Moderna COVID-19 VACCINE, Moderna COVID-19 VACCINE, Moderna COVID-19 VACCINE, Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5), Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) and Spikevax. Concurrent medical conditions included Sleep apnea (sleep apnea and uses CPAP). On 29-Sep-2023, the patient received seventh dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (worse symptoms during his covid infection). At the time of the report, COVID-19 (worse symptoms during his covid infection) outcome was unknown. For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that her husband, had also taken 9 doses of Covid vaccines and experienced worse symptoms during his covid infection around the same time that she had hers. It was reported that the patient administered SPIKEVAX 2023-2024 (Dose 8) on 29-Apr-2024, SPIKEVAX 2023-2024 (Dose 9, Booster) on 30-Jun-2024 and SPIKEVAX 2024-2025 PFS (Dose 10) on 30-Jun-2025. It was unknown if the patient experienced any additional symptoms or events. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2025-788129 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-788129:Master Case (Wife)
Sleep apnea (sleep apnea and uses CPAP)
Medical History/Concurrent Conditions: CPAP (sleep apnea and uses CPAP)